Skip to main content
SpringerLink
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kasper S, Lerman MN, McQuade RD, et al. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol 2003; 6(4): 325–37

    Article  PubMed  CAS  Google Scholar 

  2. Scientific discussion Abilify®. http://www.emea.eu.int/humandocs/Humans/EPAR/abilify/abilify.htm. Access date 13-06-2006.

  3. Loonen AJM. Effecten van atypische antipsychotica (II): werkingsmechanisme. Patiënt Care Neuropsychiatrie & Gedragsneurologie 2005; (3): 121–8

    Google Scholar 

  4. Scholten MR, Selten JP. Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug. Ned Tijdschr Geneeskd 2005; 149(41): 2296–8

    PubMed  CAS  Google Scholar 

  5. Stahl SM. Essential psychopharmacology. Second ed. Cambridge: Cambridge University Press, 2000

    Google Scholar 

  6. Langen-Wouterse JJ, van Grootheest AC, van Puijenbroek EP. Anticiperen op bijwerkingen aripiprazol. Pro-actieve bewaking van geneesmiddelenveiligheid. Pharm Weekblad 2004; 139(16): 550–4

    Google Scholar 

  7. Loonen AJM. Effecten van atypische antipsychotica (I): biologisch substraat. Patiënt Care Neuropsychiatrie & Gedragsneurologie 2005; (2): 79–84

    Google Scholar 

  8. Jenner P, Marsden CD. Adaptive changes in brain dopamine function as a result of neuroleptic treatment. Adv Neurol 1988; 49: 417–31

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, the Netherlands

    E. Beers, M. C. H. de Groot & A. C. van Grootheest

Authors
  1. E. Beers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. C. H. de Groot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. C. van Grootheest
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beers, E., de Groot, M.C.H. & van Grootheest, A.C. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 932 (2006). https://doi.org/10.2165/00002018-200629100-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00029

Keywords

Search

Navigation